Companies / KalVista Pharmaceuticals Inc

KalVista Pharmaceuticals Inc

KALVCIK 1348911FRAMINGHAM, MA

Financials · FY2025

Revenue$49.08M
Net income$-109.52M
Total debt$172.21M
Cash$213.77M
Diluted EPS$-2.03
Shares outstanding53.2M

Ownership

53.2M shares outstanding · as of May 7, 2026
19.8%10%+ / strategic
Ownership
10%+ / strategic19.81%10,547,461
Institutions117.72%62,676,795
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 20

View all →
Insider% of sharesShares
Venrock Healthcare Capital Partners III, L.P.10% owner
9.56%5,089,354
Audhya Paul K.CHIEF MEDICAL OFFICER
0.00%0
Palleiko Benjamin LCEOCHIEF EXECUTIVE OFFICER · Director
0.00%0
Piekos BrianChief Financial Officer
0.00%0
Sweeny NicoleFormerChief Commercial Officer
0.00%0
Yea ChristopherFormerCHIEF DEVELOPMENT OFFICER
0.00%0
Arif BilalFormerChief Operations Officer
——
Fairey WilliamDirector
——
Koh Bong Y10% owner
——
Pereira Brian JGDirector
——

Institutional holders 168

View all →
HolderValue% of shares
VR Adviser, LLC$108.67M12.64%
Tang Capital Management, LLC$92.07M8.59%
Frazier Life Sciences Management, L.P.$81.39M9.47%
Suvretta Capital Management, LLC$77.01M8.96%
BlackRock, Inc.$60.63M7.05%
Capital World Investors$45.36M5.28%
Vanguard Group Inc$40.52M4.71%
SilverArc Capital Management, LLC$39.20M4.56%
Millennium Management LLC$38.49M3.59%
Point72 Asset Management, L.P.$36.88M4.29%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 25, 2026Venrock Healthcare Capital Partners III, L.P.
10% owner
SellCommon Stock$2.96M-174K
-3.29%
5,129,500
9.63% of shares
medium
May 27, 2026Yea Christopher
Executive
SellCommon Stock$905.2K-34K
-12.82%
229,918
0.43% of shares
medium
Mar 26, 2026Venrock Healthcare Capital Partners III, L.P.
10% owner
SellCommon Stock$379.8K-21K
-0.42%
5,107,954
9.59% of shares
medium
May 22, 2026Palleiko Benjamin L
CEO
SellCommon Stock$292.6K-11K
-2.23%
479,989
0.90% of shares
medium
Mar 26, 2026Venrock Healthcare Capital Partners III, L.P.
10% owner
SellCommon Stock$290.1K-15K
-0.30%
5,092,537
9.57% of shares
medium
May 27, 2026Yea Christopher
Executive
ExerciseCommon Stock$239.0K+34K
+14.70%
263,718
0.50% of shares
low
Apr 17, 2026Palleiko Benjamin L
CEO
SellCommon Stock$193.1K-10K
-2.02%
462,577
0.87% of shares
medium
Feb 23, 2026Palleiko Benjamin L
CEO
SellCommon Stock$156.2K-10K
-2.22%
442,883
0.83% of shares
medium

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Point72 Asset Management, L.P.Passive13G/A———
Point72 Asset Management, L.P.Passive13G———
Glazer Capital, LLCPassive13G—2,581,700—
Millennium Management LLCPassive13G/A———
Point72 Asset Management, L.P.Passive13G/A———
SilverArc Capital Management, LLCPassive13G—2,876,407—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
KALV——483497103—